Comparison of integrated PET-CT remediastinoscopy to restage IIIA-N2 NSCLC after induction chemotherapy Source: ISSN=ISSN 1810-6838, ISBN=, page=289 Year: 2007
Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 664s Year: 2007
The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011
PET scanning poorly predicts response to pre-operative chemotherapy in non-small cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=54 Year: 2004
Role of CT and PET in detecting non-aggressive stage IA NSCLC Source: International Congress 2016 – The stage I non-small-cell lung cancer Year: 2016
Prospective evaluation of repeat integrated PET/CT scan after induction therapy for stage IIIA-N2 lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=186 Year: 2006
Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
The correlation between clinical and pathomorphological impacts of induction chemotherapy and long-term results of multimodality treatment for IIIA stage non-small cell lung cancer Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020
Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004
Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009
Mediastinoscopy versus CT and PET in preoperative N-staging of lung cancer Source: Annual Congress 2009 - Current challenges in thoracic surgery Year: 2009
Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer Source: Annual Congress 2011 - General thoracic surgery II Year: 2011
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Source: Eur Respir J 2011; 37: 162-168 Year: 2011
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019
The use of perfusion SPECT imaging for preoperative evaluation of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002